The India glass pharmaceutical packaging materials market size reached USD 680 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,560 Million by 2033, exhibiting a growth rate (CAGR) of 9.6% during 2025-2033. The market is growing due to increasing drug production, stricter regulations, and rising demand for sustainable solutions. Additionally, manufacturers are adopting lightweight, recyclable glass, while innovations in barrier coatings and durability enhance drug stability, safety, and regulatory compliance, impacting market growth by driving demand for sustainable, high-performance pharmaceutical packaging solutions.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2024 |
Forecast Years
|
2025-2033
|
Historical Years
|
2019-2024
|
Market Size in 2024 | USD 680 Million |
Market Forecast in 2033 | USD 1,560 Million |
Market Growth Rate 2025-2033 | 9.6% |
Increasing Adoption of Borosilicate Glass for Injectable Drugs
The demand for borosilicate glass in India's pharmaceutical packaging market is rising as injectable drugs, biologics, and vaccines gain prominence. With India being a leading supplier of generic injectables, manufacturers are shifting toward Type I borosilicate glass due to its high chemical resistance, thermal stability, and low extractables. For instance, according to IMARC Group, India's generic injectables market is projected to reach USD 7.6 Billion by 2033. Additionally, this shift is essential to prevent drug interactions, contamination risks, and pH alterations in sensitive formulations. Pharmaceutical companies are also upgrading their packaging materials to meet stricter regulatory standards from agencies such as the USFDA and EMA, ensuring product safety in both domestic and export markets. Moreover, increasing investments in glass manufacturing infrastructure are driving innovation in vial and ampoule production, improving dimensional accuracy and break resistance. As biologics and specialty injectables grow in demand, pharmaceutical firms are focusing on packaging that maintains drug integrity throughout the supply chain and storage lifecycle. Furthermore, with rising quality expectations from both regulators and healthcare providers, borosilicate glass packaging is becoming the preferred choice for high-value and sensitive pharmaceutical products in India.
Growing Emphasis on Lightweight and Sustainable Glass Packaging
Sustainability is becoming a key focus in India's pharmaceutical glass packaging industry, with manufacturers adopting lightweight and recyclable glass to reduce environmental impact. As regulatory bodies and pharmaceutical companies emphasize sustainable supply chains, glassmakers are developing thinner yet durable glass containers that minimize raw material usage and carbon emissions during production and transportation. The growing acceptance of lightweight glass vials and bottles also lowers logistics costs while maintaining the necessary strength for pharmaceutical storage. Additionally, recycled glass content is gaining traction as companies work toward circular economy models in packaging. Moreover, government initiatives promoting green manufacturing and corporate commitments to carbon footprint reduction are further accelerating the transition toward eco-friendly glass packaging solutions. For instance, in November 2024, the Government of India (GOI) announced the launch of two greenfield plants under the PLI scheme to strengthen domestic pharmaceutical manufacturing. These facilities will produce penicillin G, 6-APA, significantly influencing the market. As sustainability takes center stage, pharmaceutical companies are increasingly choosing low-carbon, recyclable glass packaging to align with evolving environmental regulations and global market expectations.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the region level for 2025-2033. Our report has categorized the market based on product, material, and application.
Product Insights:
The report has provided a detailed breakup and analysis of the market based on the product. This includes ampoules, bottles, vials, syringes, cartridges, and others.
Material Insights:
A detailed breakup and analysis of the market based on the material have also been provided in the report. This includes type I glass, type II glass, and type III glass.
Application Insights:
The report has provided a detailed breakup and analysis of the market based on the application. This includes oral medications, injectable medications, nasal medications, and others.
Regional Insights:
The report has also provided a comprehensive analysis of all the major regional markets, which include North India, South India, East India, and West India.
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Scope of the Report | Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
|
Products Covered | Ampoules, Bottles, Vials, Syringes, Cartridges, Others |
Materials Covered | Type I Glass, Type II Glass, Type III Glass |
Applications Covered | Oral Medications, Injectable Medications, Nasal Medications, Others |
Regions Covered | North India, South India, East India, West India |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
Key Benefits for Stakeholders: